Cremieux, Pierre-Yves; Finkelstein, Stan N.; Berndt, … - In: PharmacoEconomics 16 (1999) 5, pp. 459-472
Objective: To measure the cost effectiveness of a supportive care intervention when the no-treatment option is unrealistic in an analysis of recombinant human erythropoietin (epoetin) treatment for anaemic patients with cancer undergoing chemotherapy. Further, to assess whether quality-adjusted...